MINARIS ADVANCED THERAPIES
Live / Allowed — Notice of allowance issued (as of 05 May 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99171879
- Mark type
- Stylized text
- Filed
- 06 May 2025
- Published for opposition
- 13 Jan 2026
- Attorney of record
- KATE SHERLOCK
Goods and services
- Class 040 — Treatment of materials: Contract manufacturing in the nature of biomanufacturing for others of pharmaceuticals using biological cells in the manufacturing process; Providing information, advice and consultancy in the field of contract manufacturing in the nature of biomanufacturing for others of pharmaceuticals using biological cells in the manufacturing process
- Class 042 — Scientific and technological services: Pharmaceutical research and development services, namely, contracted cell culturing and tissue culturing for scientific purposes; scientific and technological services, namely, testing, inspection for quality control purposes, and research in the field of cell culture and tissue culture, and consultancy and information services relating thereto; pharmaceutical research and development advisory services, namely, advisory services in the field of cell culturing for scientific purposes; research and product development services in the field of cell culture and tissue culture, and consultancy relating thereto; scientific consulting and research services relating to the isolation and cultivation of body tissues and cells; advisory services for pharmaceutical drug development; scientific testing and research services in the field of pharmaceuticals and biotechnology, and advisory services relating thereto; contracted development of biological cell culturing processes; scientific laboratory services, namely, the cultivation or modification of hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration into living drugs; quality control of goods and services in the field of cell and tissue culturing, and consultancy relating thereto; quality control of goods in the nature of biological cells and living tissue for others; Scientific laboratory services relating to the isolation and cultivation of body tissues and cells for medical purposes, contracted cell culturing and tissue culturing for medical purposes, and advisory services in the field of contracted cell culturing and tissue culturing for medical purposes
- Class 044 — Medical, beauty and agricultural services: Information, advice and consultancy services relating to medical services and regenerative medicine; human tissue bank services; providing medical information; medical, medicinal and pharmaceutical consultancy; collection and preservation of human blood
Owner
- Minaris Advanced Therapies, LLC, Philadelphia, PA, US
- Minaris Advanced Therapies, LLC, Philadelphia, PA, US
Prosecution history
- 19 Aug 2026 — TEAS STATEMENT OF USE RECEIVED
- 05 May 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Mar 2026 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 11 Feb 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 13 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jan 2026 — PUBLISHED FOR OPPOSITION
- 07 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Dec 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED